These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells. Do Y; Nagarkatti PS; Nagarkatti M J Immunother; 2004; 27(1):1-12. PubMed ID: 14676629 [TBL] [Abstract][Full Text] [Related]
3. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS. Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842 [TBL] [Abstract][Full Text] [Related]
4. Mouse B cell activation is inhibited by CD44 cross-linking. Wyant TL; Fisher MT; McKallip RJ; Nagarkatti PS; Nagarkatti M; Conrad DH Immunol Invest; 2005; 34(4):399-416. PubMed ID: 16304729 [TBL] [Abstract][Full Text] [Related]
5. Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells. Oertli B; Fan X; Wüthrich RP Nephrol Dial Transplant; 1998 Feb; 13(2):271-8. PubMed ID: 9509434 [TBL] [Abstract][Full Text] [Related]
6. CD44 plays a co-stimulatory role in murine T cell activation: ligation of CD44 selectively co-stimulates IL-2 production, but not proliferation in TCR-stimulated murine Th1 cells. Sommer F; Huber M; Röllinghoff M; Lohoff M Int Immunol; 1995 Nov; 7(11):1779-86. PubMed ID: 8580076 [TBL] [Abstract][Full Text] [Related]
7. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. Hodge-Dufour J; Noble PW; Horton MR; Bao C; Wysoka M; Burdick MD; Strieter RM; Trinchieri G; Puré E J Immunol; 1997 Sep; 159(5):2492-500. PubMed ID: 9278343 [TBL] [Abstract][Full Text] [Related]
8. LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice. Wannemuehler MJ; Michalek SM; Jirillo E; Williamson SI; Hirasawa M; McGhee JR J Immunol; 1984 Jul; 133(1):299-305. PubMed ID: 6202784 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronate receptors mediating glioma cell migration and proliferation. Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. Lesley J; Howes N; Perschl A; Hyman R J Exp Med; 1994 Jul; 180(1):383-7. PubMed ID: 7516415 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437 [TBL] [Abstract][Full Text] [Related]
12. Oligosaccharides of hyaluronan are potent activators of dendritic cells. Termeer CC; Hennies J; Voith U; Ahrens T; Weiss JM; Prehm P; Simon JC J Immunol; 2000 Aug; 165(4):1863-70. PubMed ID: 10925265 [TBL] [Abstract][Full Text] [Related]
13. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Slevin M; Krupinski J; Kumar S; Gaffney J Lab Invest; 1998 Aug; 78(8):987-1003. PubMed ID: 9714186 [TBL] [Abstract][Full Text] [Related]
15. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells. Pilarski LM; Pruski E; Wizniak J; Paine D; Seeberger K; Mant MJ; Brown CB; Belch AR Blood; 1999 May; 93(9):2918-27. PubMed ID: 10216086 [TBL] [Abstract][Full Text] [Related]
16. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807 [TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies. Mustafa A; McKallip RJ; Fisher M; Duncan R; Nagarkatti PS; Nagarkatti M J Immunother; 2002; 25(6):476-88. PubMed ID: 12439345 [TBL] [Abstract][Full Text] [Related]
19. CD3-mediated T cell activation is inhibited by anti-CD44 monoclonal antibodies directed to the hyaluronan-binding region. Sugiyama K; Komada Y; Deguchi T; Zhang XL; Azuma E; Ido M; Yamamoto H; Sakurai M Immunol Invest; 1999; 28(2-3):185-200. PubMed ID: 10484683 [TBL] [Abstract][Full Text] [Related]
20. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid. Hathcock KS; Hirano H; Murakami S; Hodes RJ J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]